Futura Medical (LON:FUM) Trading 8.9% Higher – Here’s What Happened

Futura Medical plc (LON:FUM)’s share price shot up 8.9% during trading on Wednesday . The company traded as high as GBX 1.30 and last traded at GBX 1.25. 6,422,078 shares were traded during mid-day trading, an increase of 193% from the average session volume of 2,188,509 shares. The stock had previously closed at GBX 1.15.

Futura Medical Trading Up 6.4%

The company’s 50 day moving average price is GBX 1.85 and its two-hundred day moving average price is GBX 6.44. The firm has a market cap of £4.11 million, a PE ratio of -0.59 and a beta of 1.25.

Futura Medical (LON:FUM) last released its quarterly earnings results on Tuesday, September 30th. The company reported GBX (2.17) EPS for the quarter. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%. Equities research analysts expect that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Harmesh Suniara sold 4,441,678 shares of Futura Medical stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total transaction of £88,833.56. 25.86% of the stock is currently owned by insiders.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women.